-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-01-11
Values as of: 2025-01-11
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Company Website : https://www.lisata.com
Currency: USD
Country : UK
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
0R2T:LSE | Micron Technology Inc |
N/A |
USD 9,223,372,036.85B |
0R2F:LSE | Wells Fargo & Company |
N/A |
USD 9,223,372,036.85B |
0R15:LSE | SoftBank Group Corp. |
N/A |
USD 9,217.80B |
0R1E:LSE | Nintendo Co. Ltd. |
N/A |
USD 7,596.04B |
0M69:LSE | OTP Bank Nyrt |
N/A |
USD 5,014.80B |
0R28:LSE | Newmont Corp. |
N/A |
USD 4,231.43B |
0R2O:LSE | Freeport-McMoRan Inc. |
N/A |
USD 4,154.37B |
0QY4:LSE | Las Vegas Sands Corp. |
N/A |
USD 4,148.69B |
0QYD:LSE | Yum! Brands Inc. |
N/A |
USD 4,109.92B |
0QZ4:LSE | Delta Air Lines Inc. |
N/A |
USD 4,094.73B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
EATZ | AdvisorShares Restaurant .. | 5.43 % | 0.00 % |
N/A |
USD 3.34M |
HAU-U:CA | 3.45 % | 0.00 % |
N/A |
N/A | |
RCD | Invesco S&P 500® Equal W.. | 2.34 % | 0.40 % |
N/A |
N/A |
SDOG | ALPS Sector Dividend Dogs.. | 2.31 % | 0.40 % |
N/A |
USD 1.18B |
BTAL | AGFiQ U.S. Market Neutral.. | 0.45 % | 0.00 % |
N/A |
N/A |
RSP | Invesco S&P 500® Equal W.. | 0.23 % | 0.20 % |
N/A |
N/A |
XDEW:LSE | Xtrackers S&P 500 Equal W.. | 0.23 % | 0.00 % |
N/A |
N/A |
XDWE:LSE | Xtrackers (IE) Public Lim.. | 0.23 % | 0.00 % |
N/A |
N/A |
RXI | iShares Global Consumer D.. | 0.00 % | 0.46 % |
N/A |
N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike